The process of stimulating the enzyme Nitric Oxide Synthase (NOS) to increase the endogenous production of Nitric Oxide (NO), a crucial gaseous signaling molecule. NO is a potent vasodilator, regulating blood flow, blood pressure, and endothelial function, which is essential for systemic health and efficient hormonal transport. Activation of this pathway is a primary clinical target for improving cardiovascular and sexual health, both of which decline with age.
Origin
This concept is rooted in cardiovascular physiology and biochemistry, following the discovery of Nitric Oxide’s role as an endothelium-derived relaxing factor. NOS is the enzyme responsible for synthesizing NO from the amino acid L-arginine and oxygen. Age-related decline in NO bioavailability is a major, measurable factor in vascular dysfunction and endothelial aging.
Mechanism
Activation involves promoting the availability of NOS cofactors, such as tetrahydrobiopterin, or using pharmacological agents that directly stimulate the enzyme’s activity, particularly the endothelial NOS (eNOS) isoform. The resulting increase in NO diffuses to adjacent smooth muscle cells, triggering a cascade that leads to vasodilation. This action improves blood supply to all tissues, including endocrine glands and reproductive organs, thereby enhancing their function and metabolic exchange.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.